CVE-2015-8350

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in the Calls to Action plugin before 2.5.1 for WordPress allow remote attackers to inject arbitrary web script or HTML via the (1) open-tab parameter in a wp_cta_global_settings action to wp-admin/edit.php or (2) wp-cta-variation-id parameter to ab-testing-call-to-action-example/.

Category

6.1
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.43%
Third-Party Advisory packetstormsecurity.com Third-Party Advisory wordpress.org Third-Party Advisory htbridge.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.htbridge.com/advisory/HTB23274 third party advisory exploit
https://wordpress.org/plugins/cta/#developers third party advisory release notes
http://packetstormsecurity.com/files/134598/WordPress-Calls-To-Action-2.4.3-Cross-Site-Scripting.html vdb entry third party advisory
http://www.securityfocus.com/archive/1/537022/100/0/threaded mailing list

Frequently Asked Questions

What is the severity of CVE-2015-8350?
CVE-2015-8350 has been scored as a medium severity vulnerability.
How to fix CVE-2015-8350?
To fix CVE-2015-8350, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-8350 being actively exploited in the wild?
It is possible that CVE-2015-8350 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.